Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Opinion in Pharmacology|June 16, 2014
NSAID-gastroenteropathy: new aspects of pathogenesis and preventionRory W Blackler, Burcu Gemici, Anna Manko, et al.Nitric Oxide : Biology and Chemistry|April 22, 2014
Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancerWagdi Elsheikh, Rory W Blackler, Kyle L Flannigan, et al.British Journal of Pharmacology|October 10, 2014
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiotaRory W Blackler, Jean-Paul Motta, Anna Manko, et al.Proceedings of the National Academy of Sciences of the United States of America|September 5, 2014
Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitisKyle L Flannigan, Terence A Agbor, Rory W Blackler, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|April 18, 2015
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAIDRory W Blackler, Giada De Palma, Anna Manko, et al.Journal of Gastroenterology|January 10, 2015
NSAID enteropathy and bacteria: a complicated relationshipStephanie D Syer, Rory W Blackler, Rebeca Martin, et al.Inflammatory Bowel Diseases|March 5, 2015
Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus productionJean-Paul Motta, Kyle L Flannigan, Terence A Agbor, et al.Pageof 1